Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Yes Bank approaches...

    Yes Bank approaches NCLT against Jaypee Healthcare to start insolvency process

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-12-04T13:35:47+05:30  |  Updated On 4 Dec 2019 1:35 PM IST

    New Delhi: Yes Bank has approached the National Company Law Tribunal (NCLT), Allahabad to initiate insolvency proceedings against Jaypee Healthcare, which is a subsidiary of bankrupt Jaypee Infratech.


    Crisis-hit Jaypee group's flagship firm Jaiprakash Associates Ltd (JAL) is the promoter of Jaypee Infratech.


    "A petition is under filing by Yes Bank Ltd under section 7 of the Insolvency and Bankruptcy Code, 2016 before National Company Law Tribunal (NCLT), Allahabad to initiate Corporate Insolvency Resolution Process against Jaypee Healthcare Ltd (a subsidiary of the company)," the company said in a filing to the exchange.


    Already, Jaypee Infratech is facing the insolvency proceedings. Its affairs, business and assets are being managed by the Interim Resolution Professional (IRP) Anuj Jain.


    In the first round of insolvency proceedings of Jaypee Infratech conducted last year, Rs 7,350-crore bid of Lakshdeep, part of Suraksha Group, was rejected by lenders.


    During May-June this year, lenders rejected the bids of Suraksha Realty and NBCC in the second round.


    The matter reached to the National Company Law Appellate Tribunal (NCLAT) and then the Supreme Court.


    On November 6, the Supreme Court directed completion of Jaypee Infratech's insolvency process within 90 days and said the revised resolution plan will be invited only from NBCC and Suraksha Realty.


    Read Also: Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore


    As many as 13 banks and over 23,000 homebuyers have voting rights in the CoC. Buyers have nearly 60 per cent votes. For a bid to be approved, 66 per cent votes are required. Total claim admitted is over Rs 23,000 crore, of which around Rs 13,000 crore pertains to home buyers and rest of 13 banks.


    Read Also:Single-member NCLT bench to give finality to split verdict over Unimark Remedies resolution

    bankruptinsolvency processJaypee HealthcareNational Company Law TribunalNBCCNCLTYes Bank
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok